Skip to main content

Name
Joseph Nashed

Tue, 09/24/2019 - 11:33

I thought Dr. Gerszten's talk was really interesting, and although I am just being introduced to the field of metabolomics, one of the things that really stood out to me from Dr. Gerszten's talk was how metabolomics and proteomics could be used in personalized medicine - specifically predict the future development of this diseases like DM and CVD. Dr. Gerszten emphasized the importance of these tools and how they could be used to place people in prognostic categories, which could eventually lead to more specific treatment plans and interventions. In our discussion, Dr. Gerszten easily convinced me of the importance of one day having metabolomic and proteomic profiles similar to the human genome project, and how valuable that would be in medicine.

Thank you again Dr. Gerszten!

Name
Joseph Nashed

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.